UNITED STATES  

SECURITIES AND EXCHANGE COMMISSION  

Washington, D.C. 20549  

 

FORM 10-Q

 

(MARK ONE)  

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

 

For the quarter ended June 30, 2021  

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  

 

For the transition period from                    to                    

 

Commission file number: 001-40152  

 

INTERPRIVATE II ACQUISITION CORP.

(Exact Name of Registrant as Specified in Its Charter)  

 

Delaware       85-3122877  
(State or other jurisdiction of
incorporation or organization)  
    (I.R.S. Employer
Identification No.)

 

1350 Avenue of the Americas, 2nd Floor  

New York, NY 10019  

(Address of principal executive offices)  

 

(212) 920-0125  

(Issuer’s telephone number)  

 

Securities registered pursuant to Section 12(b) of the Act:  

 

Title of each class       Trading Symbol(s)       Name of each exchange on which registered  
Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant       IPVA.U       The New York Stock Exchange  
Class A common stock, par value $0.0001 per share       IPVA       The New York Stock Exchange  
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share       IPVA WS       The New York Stock Exchange  

   

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐  

   

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐  

   

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.  

   

Large accelerated filer   ☐   Accelerated filer   ☐  
Non-accelerated filer   ☒   Smaller reporting company     
    Emerging growth company     

   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

   

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No ☐  

   

As of August 18, 2021, there were 26,075,000 shares of Class A common stock, $0.0001 par value and 6,468,750 shares of Class B common stock, $0.0001 par value, issued and outstanding.

 

 

  

 

 

    

INTERPRIVATE II ACQUISITION CORP.  

 

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2021  

 

TABLE OF CONTENTS  

 

    Page  
Part I. Financial Information    
Item 1. Financial Statements 1
Condensed Balance Sheet (Unaudited) 1
Condensed Statement of Operations (Unaudited)  2
Condensed Statement of Changes in Stockholders’ Equity (Unaudited)  3
Condensed Statement of Cash Flows (Unaudited)  4
Notes to Condensed Financial Statements (Unaudited) 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations  19
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk  21
Item 4. Controls and Procedures 22
       
Part II. Other Information     
Item 1. Legal Proceedings 23
Item 1A. Risk Factors   23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds  23
Item 3. Defaults Upon Senior Securities   23
Item 4. Mine Safety Disclosures   23
Item 5. Other Information   23
Item 6. Exhibits   24
       
Part III. Signatures   25

  

i

 

   

PART I - FINANCIAL INFORMATION

   

Item 1. Interim Financial Statements.  

   

INTERPRIVATE II ACQUISITION CORP.  

CONDENSED BALANCE SHEET  

  

   June 30, 
   2021 
   (unaudited) 
ASSETS    
Current assets    
Cash  $369,004 
Prepaid expenses   429,247 
Total Current Assets   798,251 
      
Marketable securities held in Trust Account   258,770,580 
TOTAL ASSETS  $259,568,831 
      
LIABILITIES AND STOCKHOLDERS’ EQUITY     
Current liabilities     
Accounts payable and accrued expenses  $487,565 
Total Current Liabilities   487,565 
      
Warrant liability   5,163,667 
Total Liabilities   5,651,232 
      
Commitments and Contingencies (See Note 6)   
 
 
Class A common stock subject to possible redemption 24,891,760 shares at redemption value at June 30, 2021   248,917,597 
      
Stockholders’ Equity     
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding   
 
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; 1,183,240 shares issued and outstanding (excluding 24,891,760 shares subject to possible redemption)   118 
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,468,750 shares issued and outstanding   647 
Additional paid-in capital   7,569,007 
Accumulated deficit   (2,569,770)
Total Stockholders’ Equity   5,000,002 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $259,568,831 

   

 The accompanying notes are an integral part of the unaudited condensed financial statements.

   

1

 

   

INTERPRIVATE II ACQUISITION CORP.

CONDENSED STATEMENT OF OPERATIONS

THREE AND SIX  MONTHS ENDED JUNE 30, 2021

(UNAUDITED)

   

   Three Months   Six Months 
   Ended   Ended 
   June 30,
2021
   June 30,
2021
 
         
Operating and formation costs  $855,219   $936,681 
Loss from operations   (855,219)   (936,681)
           
Other income (expense):          
Change in fair value of warrant liabilities   (1,900,667)   (1,646,833)
Offering costs attributable to warrant liabilities       (6,835)
Interest earned on marketable securities held in Trust Account   19,485    23,982 
Unrealized loss on marketable securities held in Trust Account   (7,711)   (3,403)
Other income, net   (1,888,893)   (2,569,770)
           
(Loss) income before income taxes   (2,744,112)   (2,569,770)
Provision for income taxes   
    
 
Net loss  $(2,744,112)  $(2,569,770)
           
Basic and diluted weighted average shares outstanding, Class A common stock subject to redemption   25,166,171    25,150,926 
           
Basic and diluted net income per share, Class A common stock subject to redemption   
    
 
           
Basic and diluted weighted average shares outstanding, Non-redeemable common stock  $7,377,579    6,806,056 
           
Basic and diluted net loss per share,  Non-redeemable common stock  $(0.37)  $(0.38)

  

The accompanying notes are an integral part of the unaudited condensed financial statements.  

   

2

 

    

INTERPRIVATE II ACQUISITION CORP.  

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY  

THREE AND SIX MONTHS ENDED JUNE 30, 2021  

(UNAUDITED)  

 

   Class A
Common Stock
   Class B
Common Stock
   Additional
Paid-in
   Retained
Earnings
(Accumulated
   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Capital   Deficit)   Equity 
Balance — January 1, 2021   
   $
    
   $
   $
   $
   $ 

Issuance of Class B common stock to Sponsor

   0        6,468,750   647   24,353      25,000 
                                    
Sale of 25,875,000 Units, net of underwriting discounts   25,875,000    2,588        
    253,051,596    
    253,054,184 
                                    
Sale of 4,616,667 Private Placement Warrants       
        
    3,408,166    
    3,408,166 
                                    
Issuance of Representative Shares   200,000    20        
    
    
    20 
                                    
Common stock subject to possible redemption   (25,149,083)   (2,516)       
    (251,488,310)   
    (251,490,826)
                                    
Change in value of common stock subject to redemption   (17,088)   (2)       
    (170,882)   
    (170,884)
                                    
Net loss       
        
    
    174,342    174,342 
                                    
Balance – March 31, 2021   908,829   $90    6,468,750   $647   $4,824,923   $174,342   $5,000,002 
                                    
Change in value of common stock subject to redemption   274,411    28              2,744,084         2,744,112 
                                    
Net income (loss)                            (2,744,112)   (2,744,112)
                                    
Balance – June 30, 2021   1,183,240   $118    6,468,750   $647   $7,569,007   $(2,569,770)  $5,000,002 

     

The accompanying notes are an integral part of the unaudited condensed financial statements.  

   

3

 

   

INTERPRIVATE II ACQUISITION CORP.  

CONDENSED STATEMENT OF CASH FLOWS  

SIX MONTHS ENDED JUNE 30, 2021  

(UNAUDITED)  

  

   Six Months 
   Ended 
   June 30,
2021
 
Cash Flows from Operating Activities:    
Net loss  $(2,569,770)
Adjustments to reconcile net loss to net cash used in operating activities:     
Change in fair value of warrant liabilities   1,646,833 
Offering costs attributable to warrant liabilities   6,835 
Interest earned on marketable securities held in Trust Account   (23,982)
Unrealized loss on marketable securities held in Trust Account   3,403 
Changes in operating assets and liabilities:     
Prepaid expenses and other current assets   (429,229)
Accrued expenses   487,565 
Net cash used in operating activities   (878,345)
      
Cash Flows from Investing Activities:     
Investment of cash in Trust Account   (258,750,000)
Net cash used in investing activities   (258,750,000)
      
Cash Flows from Financing Activities:     
Proceeds from sale of Units, net of underwriting discounts paid   253,575,000 
Proceeds from sale of Private Placement Warrants   6,925,000 
Proceeds from promissory note – related party   149,476 
Repayment of promissory note – related party   (149,476)
Payment of offering costs   (502,651)
Net cash provided by financing activities   259,997,349 
      
Net Change in Cash   369,004 
Cash – Beginning of period   
 
Cash – End of period  $369,004 
      
Non-Cash investing and financing activities:     
Offering costs paid by Sponsor in exchange for issuance of Founder Shares  $25,000 
Issuance of Representative Shares  $20 
Initial classification of common stock subject to possible redemption  $251,490,826 
Change in value of common stock subject to possible redemption  $(2,573,227)

 

The accompanying notes are an integral part of the unaudited condensed financial statements.  

    

4

 

 

INTERPRIVATE II ACQUISITION CORP.  
NOTES TO CONDENSED FINANCIAL STATEMENTS JUNE 30, 2021  
(Unaudited)

   

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS  

   

InterPrivate II Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on September 10, 2020. It was originally incorporated under the name “InterPrivate IV Capital Partners Corp.”, but the Company changed its name to “InterPrivate II Acquisition Corp.” on January 6, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”).  

   

The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.  

   

As of June 30, 2021, the Company had not yet commenced any operations. All activity through June 30, 2021 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.  

   

The registration statement for the Company’s Initial Public Offering was declared effective on March 4, 2021. On March 9, 2021, the Company consummated the Initial Public Offering of 25,875,000 units (the “Units”), which includes the full exercise by the underwriter of its over-allotment option in the amount of 3,375,000 Units, at $10.00 per Unit, generating gross proceeds of $258,750,000, which is described in Note 3.  

   

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,616,667 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to InterPrivate Acquisition Management II LLC (the “Sponsor”) and EarlyBirdCapital, Inc. (“EarlyBirdCapital”), generating gross proceeds of $6,925,000, which is described in Note 4.  

   

Transaction costs amounted to $5,691,351, consisting of $5,175,000 of underwriting fees and $516,351 of other offering costs.  

   

Following the closing of the Initial Public Offering on March 9, 2021, an amount of $258,750,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below.  

   

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NYSE rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.  

   

5

 

 

INTERPRIVATE II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)  

   

The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.  

   

The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and EarlyBirdCapital have agreed to vote their Founder Shares (as defined in Note 5), Representative Shares, respectively (as defined in Note 8) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.  

   

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.  

   

The Sponsor and EarlyBirdCapital have agreed (a) to waive their redemption rights with respect to their Founder Shares, Representative Shares and Public Shares held by them in connection with the completion of a Business Combination, (b) waive their liquidation rights with respect to the Founder Shares and Representative Shares if the Company fails to complete a Business Combination and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination.  

   

6

 

 

INTERPRIVATE II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)  

   

The Company will have until March 9, 2023 or any extended period of time that the Company may have to consummate a Business Combination as a result of an amendment to the Company’s Amended and Restated Certificate of Incorporation to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.  

   

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.  

   

Risks and Uncertainties  

   

Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statement do not include any adjustments that might result from the outcome of this uncertainty.  

   

7

 

 

INTERPRIVATE II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)  

   

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  

   

Basis of Presentation  

   

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.  

   

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on March 04, 2021, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on March 15, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods.  

   

Emerging Growth Company  

   

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.  

   

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.  

   

Use of Estimates  

   

The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  

   

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.  

   

Liquidity and Financial Condition  

   

We will need to raise additional capital through loans or additional investments from our initial stockholders, officers or directors. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. These conditions raise substantial doubt about our ability to continue as a going concern through one year and one day from the issuance of this report.  

   

Offering Costs Associated with the Initial Public Offering  

   

The Company complies with the requirements of the Accounting Standards Codification (the “ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A — “Expenses of Offering.” Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to our Public Offering and were charged to stockholders’ equity upon the completion of our Public Offering.  

  

8

 

 

INTERPRIVATE II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)  

   

Cash and Cash Equivalents  

   

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021.  

   

Marketable Securities Held in Trust Account  

   

At June 30, 2021, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities.  

   

Warrant Liability  

   

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.  

   

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the warrants was estimated using a Binomial Lattice Model (see Note 9).  

   

Class A Common Stock Subject to Possible Redemption  

   

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2021, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.  

   

9

 

  

INTERPRIVATE II ACQUISITION CORP.  
NOTES TO CONDENSED FINANCIAL STATEMENTS  
JUNE 30, 2021  
(Unaudited)  

   

Income Taxes  

   

The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.  

   

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The effective tax rate differs from the statutory tax rate of 21% for the six months ended June 30, 2021, due to the valuation allowance recorded on the Company’s net operating losses.  

   

Net Income (Loss) per Common Share  

   

Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture.  

   

The Company’s statement of operations includes a presentation of income (loss) per share for common stock subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss) per common share, basic and diluted, for Class A common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Class A common stock subject to possible redemption outstanding since original issuance.  

   

Net income (loss) per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Class A common stock subject to possible redemption, by the weighted average number of non-redeemable common stock outstanding for the period.  

   

Non-redeemable common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. Non-redeemable common stock participates in the income or loss on marketable securities based on non-redeemable shares’ proportionate interest.  

   

10

 

 

INTERPRIVATE II ACQUISITION CORP.  
NOTES TO CONDENSED FINANCIAL STATEMENTS  
JUNE 30, 2021  
(Unaudited)  

   

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):  

  

   Three Months   Six Months 
   Ended   Ended 
   June 30,   June 30, 
   2021   2021 
Class A common stock subject to possible redemption        
Numerator: Earnings attributable to Class A common stock subject to possible redemption          
Interest earned on marketable securities held in Trust Account  $18,745   $23,071 
Unrealized loss on marketable securities held in Trust Account   (7,418)   (3,274)
Less: interest available to be withdrawn for payment of taxes   (11,327)   (19,797)
Net income attributable to Class A ordinary shares subject to possible redemption  $
   $
 
Denominator: Weighted Average Class A common stock subject to possible redemption          
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption   25,166,171    25,162,844 
Basic and diluted Net Loss per share, Class A common stock subject to possible redemption  $
   $
 
           
Non-Redeemable Common Stock          
Numerator: Net Loss minus Net Earnings          
Net Loss  $(2,744,112)  $(2,569,770)
Less: Net Loss allocable to Class A common stock subject to possible redemption   
    
 
Non-Redeemable Net Income  $(2,744,112)  $(2,569,770)
Denominator: Weighted Average Non-redeemable common stock          
Basic and diluted weighted average shares outstanding, non-redeemable common stock   7,377,579    6,808,056 
Basic and diluted net loss per share, non-redeemable common stock  $(0.37)  $(0.38)

   

Concentration of Credit Risk  

   

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.  

   

Fair Value of Financial Instruments  

   

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.  

   

Recent Accounting Standards  

   

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.  

   

11

 

  

INTERPRIVATE II ACQUISITION CORP. 
NOTES TO CONDENSED FINANCIAL STATEMENTS 
JUNE 30, 2021 
(Unaudited) 

 

NOTE 3. PUBLIC OFFERING 

 

Pursuant to the Initial Public Offering, the Company sold 25,875,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,375,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-fifth of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share

 

Transaction costs amounted to $5,691,351, consisting of $5,175,000 of underwriting fees and $516,351 of other offering costs. In addition, cash of $1,638,850 was held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes. 

 

NOTE 4. PRIVATE PLACEMENT 

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital purchased an aggregate of 4,616,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, or $6,925,000 in the aggregate. The Sponsor purchased an aggregate of 3,850,000 Private Placement Warrants and EarlyBirdCapital purchased an aggregate of 766,667 Private Placement Warrants. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

 

NOTE 5. RELATED PARTY TRANSACTIONS 

 

Founder Shares 

 

On January 13, 2021, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 5,750,000 shares of Class B common stock (the “Founder Shares”). On March 4, 2021, the Company effected a 1:1.125 stock split of its Class B common stock, resulting in an aggregate of 6,468,750 Founder Shares issued and outstanding. The Founder Shares included an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment was not exercised in full or in part, so that the Sponsor would collectively own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering and excluding the Representative Shares). As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture. 

 

The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until (i) with respect to 50% of such shares, for a period ending on the earlier of the one-year anniversary of the date of the consummation of a Business Combination and the date on which the closing price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period following the consummation of a Business Combination and (ii) with respect to the remaining 50% of such shares, for a period ending on the one-year anniversary of the date of the consummation of a Business Combination, or, in either case, earlier if, subsequent to a Business Combination, the Company consummates a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. 

 

Administrative Services Agreement 

 

The Company entered into an agreement, commencing on March 4, 2021, pursuant to which the Company will pay the Sponsor a total of up to $10,000 per month for office space, administrative and support services. Upon completion of the Business Combination or the Company’s liquidation, the agreement will terminate and the Company will cease paying these monthly fees. For the three and six months ended June 30, 2021, the Company incurred and paid $30,000 and $40,000 in fees for these services, respectively.  

 

12

 

 

INTERPRIVATE II ACQUISITION CORP. 
NOTES TO CONDENSED FINANCIAL STATEMENTS 
JUNE 30, 2021 
(Unaudited) 

 

Promissory Note — Related Party 

 

On January 13, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and was payable on the earlier of (i) December 31, 2021 or (ii) the consummation of the Initial Public Offering. As of March 9, 2021, there was $149,476 outstanding under the Promissory Note, which was repaid on March 10, 2021. 

 

Related Party Loans 

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. 

 

Services Agreement 

 

The Company entered into an agreement, pursuant to which the Company will pay its Vice President a total of $10,000 per month for assisting the Company in negotiating and consummating an initial Business Combination. Upon completion of the Business Combination or the Company’s liquidation, the agreement will terminate and the Company will cease paying these monthly fees. For the six months ended June 30, 2021, the Company incurred and paid $40,000 in fees for these services, respectively. For the three and six months ended June 30, 2021, the Company incurred and paid $30,000 and $40,000 in fees for these services, respectively.    

 

13

 

 

INTERPRIVATE II ACQUISITION CORP. 
NOTES TO CONDENSED FINANCIAL STATEMENTS 
JUNE 30, 2021 
(Unaudited) 

 

NOTE 6. COMMITMENTS AND CONTINGENCIES 

 

Registration Rights 

 

Pursuant to a registration rights agreement entered into on March 4, 2021, the holders of the Founder Shares, Representative Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) have registration rights requiring the Company to register a sale of any of the securities held by them prior to the consummation of a Business Combination. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy- back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. 

 

Business Combination Marketing Agreement 

 

The Company has engaged Morgan Stanley and EarlyBirdCapital as advisors in connection with the Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with the Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay Morgan Stanley and EarlyBirdCapital a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds, or $9,056,250, of the Initial Public Offering (exclusive of any applicable finders’ fees which might become payable).  

 

NOTE 7. STOCKHOLDERS’ EQUITY 

 

Preferred StockThe Company is authorized to issue 1,000,000 shares of $0.0001 par value preferred stock. At June 30, 2021, there were no shares of preferred stock issued or outstanding. 

 

Class A Common Stock— The Company is authorized to issue up to 380,000,000 shares of Class A, $0.0001 par value common stock. Holders of the Company’s common stock are entitled to one vote for each share. At June 30, 2021, there were 1,183,240 of Class A common stock issued and outstanding, excluding 24,891,760 shares of Class A common stock subject to possible redemption. 

 

Class B Common Stock— The Company is authorized to issue up to 20,000,000 shares of Class B, $0.0001 par value common stock. Holders of the Company’s common stock are entitled to one vote for each share. At June 30, 2021, there were 6,468,750 shares of Class B common stock issued and outstanding. 

 

Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law. 

 

The shares of Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of  Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of shares of Class B common stock will never occur on a less than one-for-one basis. 

 

14

 

 

INTERPRIVATE II ACQUISITION CORP. 
NOTES TO CONDENSED FINANCIAL STATEMENTS 
JUNE 30, 2021 
(Unaudited) 

 

NOTE 8. WARRANTS 

 

Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable 30 days after the consummation of a Business Combination. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. 

 

The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. 

 

The Company has agreed that as soon as practicable, but in no event later than twenty (20) business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3 (a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. 

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants: 

 

  ●  in whole and not in part; 

 

  ●  at a price of $0.01 per warrant; 

 

  ●  upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and 

 

  ●  if, and only if, the closing price of the Class A common stock for any 20 trading days within a 30- trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders equals or exceeds $18.00 per share (as adjusted). 

 

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. 

 

The exercise price and number of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. 

 

15

 

 

INTERPRIVATE II ACQUISITION CORP. 
NOTES TO CONDENSED FINANCIAL STATEMENTS 
JUNE 30, 2021 
(Unaudited) 

 

In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 80% of the higher of the Market Value and the Newly Issued Price. 

 

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants will and the common shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. 

 

Representative Shares 

 

The Company issued to EarlyBirdCapital and its designees 200,000 shares of Class A common stock (the “Representative Shares”). The Company accounted for the Representative Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of Representative Shares to be $2,000,000 based upon the price of the Units issued in the Initial Public Offering. The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to vote such shares in favor of any proposed Business Combination, (ii) to waive their redemption rights with respect to such shares in connection with the completion of a Business Combination and (iii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period.  

 

The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(g)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. 

 

16

 

 

INTERPRIVATE II ACQUISITION CORP. 
NOTES TO CONDENSED FINANCIAL STATEMENTS 
JUNE 30, 2021 
(Unaudited) 

 

NOTE 9. FAIR VALUE MEASUREMENTS 

 

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. 

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: 

 

  Level 1:  Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. 
     
  Level 2:  Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. 
     
  Level 3:  Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. 

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: 

 

Description  Level  June 30, 
2021
 
Assets:       
Marketable securities held in Trust Account  1  $258,770,580 
Liabilities:        
Warrant Liability – Private Placement Warrants  3   4,466,000 
Warrant Liability – Underwriters Warrants  3   697,667 

 

The Private Placement Warrants were initially valued using a Binomial Lattice Model, which is considered to be a Level 3 fair value measurement. The Binomial Lattice Model’s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. A Binomial Lattice Model was used in estimating the fair value of the Private Placement Warrants for periods where no observable traded price was available. 

 

17

 

 

INTERPRIVATE II ACQUISITION CORP. 
NOTES TO CONDENSED FINANCIAL STATEMENTS 
JUNE 30, 2021 
(Unaudited) 

 

The key inputs into the Binomial Lattice Model for the initial measurement of Private Placement Warrants and subsequent measurement of the Private Placement Warrants are as follows: 

 

Term  March 9, 
2021
   March 31, 2021   June 30, 
2021
 
Risk-free interest rate   1.00%   0.99%   0.90%
Market price of public stock  $9.84   $9.74   $9.70 
Dividend Yield   0.00%   0.00%   0.00%
Implied volatility   13.1%   13.1%   18.8%
Exercise price  $11.50   $11.50   $11.50 

  

On March 9, 2021, March 31, 2021 and June 30, 2021, the Private Placement Warrants were determined to be valued at $0.79, $0.74 and $1.16 per warrant respectively. Underwriter Warrants on March 9, 2021, March 31, 2021 and June 30, 2021 were valued at $0.62, $0.54 and $0.91 respectively.

 

The following table presents the changes in the fair value of warrant liabilities: 

 

   Private 
Placement
   Underwriters 
Warrants
 
Fair value as of March 9, 2021  $3,041,500   $475,334 
Change in valuation inputs or other assumptions   (192,500)   (61,334)
Fair value as of March 31, 2021  $2,849,000   $414,000 
Change in valuation inputs or other assumptions   1,617,000    283,667 
Fair value as of June 30, 2021  $4,466,000   $697,667 

 

During the six-month period ended June 30, 2021 there were no transfers out of Level 3. 

 

NOTE 10. SUBSEQUENT EVENTS 

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. 

 

18

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 

 

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to InterPrivate II Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to InterPrivate Acquisition Management II LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties. 

 

Special Note Regarding Forward-Looking Statements 

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. 

 

Overview 

 

We are a blank check company formed under the laws of the State of Delaware on September 10, 2020 for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt. 

 

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful. 

 

Results of Operations 

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities through June 30, 2021 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses. 

 

For the six months ended June 30, 2021, we had a net loss of $2,569,770 which consists of operating costs of $936,681 and warrant transaction costs of $6,835, change in fair value on warrant liability of $1,646,833, interest income on marketable securities held in the Trust Account of $23,982 and an unrealized loss on marketable securities held in the Trust Account of $3,403. 

 

19

 

 

Liquidity and Capital Resources 

 

On March 9, 2021, we consummated the Initial Public Offering of 25,875,000 Units which includes the full exercise by the underwriter of its over-allotment option in the amount of 3,375,000 Units, at $10.00 per Unit, generating gross proceeds of $258,750,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 4,616,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor and EarlyBirdCapital, generating gross proceeds of $6,925,000. 

 

For the six months ended June 30, 2021, cash used in operating activities was $878,345. Net loss of $2,569,770 was affected by a non-cash charge related to the change in warrant liability of $1,646,833, interest earned on marketable securities held in the Trust Account of $23,982 and an unrealized loss on marketable securities held in in the Trust Account of $3,403 and offering costs allocable to warrant liabilities of $6,835. Changes in operating assets and liabilities provided $58,336 of cash for operating activities. 

 

As of June 30, 2021, we had marketable securities held in the Trust Account of $258,770,580 (including $23,982 of interest income and unrealized gains consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through June 30,2021, we have not withdrawn any interest earned from the Trust Account. 

 

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. 

 

As of June 30, 2021, we had cash of $369,004. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination. 

 

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.50 per warrant, at the option of the lender. The units would be identical to the Private Placement Warrants. 

 

We will need to raise additional capital through loans or additional investments from our initial stockholders, officers or directors. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. These conditions raise substantial doubt about our ability to continue as a going concern through one year and one day from the issuance of this report. 

 

Off-Balance Sheet Arrangements 

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets. 

 

20

 

 

Contractual obligations 

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000 for office space, administrative and support services. We began incurring these fees on March 4, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation. 

 

We have entered into an agreement, pursuant to which will pay the Vice President a total of $10,000 per month for assisting us in negotiating and consummating an initial Business Combination. Upon completion of the Business Combination or the Company’s liquidation, the agreement will terminate and the Company will cease paying these monthly fees. 

 

Critical Accounting Policies 

 

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies: 

 

Warrant Liability 

 

The Company accounts for the Private Placement Warrants in accordance with the guidance contained in ASC 815-40, under which the Private Placement Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Under ASC 815-40, the Company’s Private Placement Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC 815-40 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. Accordingly, the Company classifies the Private Placement Warrants as liabilities at their fair value and adjusts the Private Placement Warrants to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statement of operations. The Private Placement Warrants are valued using a binomial lattice model. 

 

Common Stock Subject to Possible Redemption 

 

We account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of our condensed balance sheets. 

 

Net Loss Per Common Share 

 

We apply the two-class method in calculating earnings per share. Net income (loss) per common share, basic and diluted for Class A common stock subject to possible redemption is calculated by dividing the interest income earned on the Trust Account, net of applicable taxes, if any, by the weighted average number of shares of Class A common stock subject to possible redemption outstanding for the period. Net income (loss) per common share, basic and diluted for and non-redeemable common stock is calculated by dividing net loss less income attributable to Class A common stock subject to possible redemption, by the weighted average number of shares of non-redeemable common stock outstanding for the period presented. 

 

Recent Accounting Standards 

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements. 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk 

 

Not required for smaller reporting companies. 

 

21

 

 

Item 4. Controls and Procedures 

 

Evaluation of Disclosure Controls and Procedures 

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer (who serves as our Principal Executive Officer) and Chief Financial Officer (who serves as our Principal Financial and Accounting Officer), as appropriate, to allow timely decisions regarding required disclosure. 

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective as of June 30, 2021, due solely to the material weakness in our internal control over financial reporting previously disclosed on our Quarterly Report on Form 10-Q for the period ended March 31, 2021 regarding the classification of the Company’s Private Placement Warrants as components of equity instead of as derivative liabilities. Notwithstanding this identified material weakness as of June 30, 2021, management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented in conformity with GAAP. 

 

Changes in Internal Control over Financial Reporting 

 

In light of the material weakness described above, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with GAAP. Management has implemented remediation steps to address the material weakness and to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex securities and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

 

While we took considerable action to remediate the material weakness, such remediation has not been fully evidenced. Accordingly, we continue to test our controls implemented in the second quarter to assess whether our controls are operating effectively. While there can be no assurance, we believe our material weakness will be remediated during the course of fiscal 2021. 

 

Other than the changes discussed above, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

22

 

 

PART II - OTHER INFORMATION 

 

Item 1. Legal Proceedings 

 

None 

 

Item 1A. Risk Factors 

 

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 filed with the SEC on July 23, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. 

 

As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 filed with the SEC on July 23, 2021. However, we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.  

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 

 

On March 9, 2021, we consummated the Initial Public Offering of 25,875,000 Units which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,375,000 Units, at $10.00 per Unit, generating gross proceeds of $258,750,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 692,500 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor and EarlyBirdCapital generating gross proceeds of $6,925,000. 

 

Following the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Private Placement Warrants, a total of $258,750,000 was placed in the Trust Account. We incurred $5,691,351 in Initial Public Offering related costs, including $5,175,000 of underwriting fees and $516,351 of other costs. 

 

The Private Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants are not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. 

 

Of the gross proceeds received from the Initial Public Offering, the exercise of the over-allotment option and the Private Placement Warrants, an aggregate of $258,750,000 was placed in the Trust Account. 

 

We paid a total of $5,175,000 in underwriting commissions and $516,351 for other costs and expenses related to the Initial Public Offering. 

 

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q. 

 

Item 3. Defaults Upon Senior Securities 

 

Not required for smaller reporting companies. 

 

Item 4. Mine Safety Disclosures 

 

None 

 

Item 5. Other Information 

 

On June 2, 2021, the Company’s board of directors appointed Tracey Brophy Warson, one of its independent directors, to serve on the Company’s Audit Committee. 

 

23

 

 

Item 6. Exhibits 

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q. 

 

No.    Description of Exhibit 
31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 
32.1*    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 
101.INS*   Inline XBRL Instance Document.
101.SCH*   Inline XBRL Taxonomy Extension Schema Document.
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

  

Filed herewith. 

 

24

 

 

SIGNATURES 

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

 

  INTERPRIVATE II ACQUISITION CORP. 
     
Date: August 18, 2021  By:  /s/ Ahmed Fattouh 
  Name:   Ahmed Fattouh 
  Title:  Chairman and Chief Executive Officer 
    (Principal Executive, Financial and Accounting Officer) 

 

 

25

 

 

false --12-31 Q2 0001839608 Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. 0001839608 2021-01-01 2021-06-30 0001839608 us-gaap:CommonClassAMember 2021-08-18 0001839608 us-gaap:CommonClassBMember 2021-08-18 0001839608 2021-06-30 0001839608 us-gaap:CommonClassAMember 2021-06-30 0001839608 us-gaap:CommonClassBMember 2021-06-30 0001839608 2021-04-01 2021-06-30 0001839608 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001839608 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001839608 ipva:NonRedeemableCommonStockMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001839608 ipva:NonRedeemableCommonStockMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001839608 ipva:NonRedeemableCommonStockMember 2021-04-01 2021-06-30 0001839608 ipva:NonRedeemableCommonStockMember 2021-01-01 2021-06-30 0001839608 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001839608 us-gaap:CommonClassBMember ipva:CommonStockOneMember 2020-12-31 0001839608 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001839608 us-gaap:RetainedEarningsMember 2020-12-31 0001839608 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001839608 us-gaap:CommonClassBMember ipva:CommonStockOneMember 2021-01-01 2021-03-31 0001839608 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001839608 2021-01-01 2021-03-31 0001839608 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001839608 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001839608 us-gaap:CommonClassBMember ipva:CommonStockOneMember 2021-03-31 0001839608 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001839608 us-gaap:RetainedEarningsMember 2021-03-31 0001839608 2021-03-31 0001839608 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001839608 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001839608 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001839608 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001839608 us-gaap:CommonClassBMember ipva:CommonStockOneMember 2021-06-30 0001839608 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001839608 us-gaap:RetainedEarningsMember 2021-06-30 0001839608 2020-12-31 0001839608 us-gaap:IPOMember 2021-03-09 0001839608 us-gaap:IPOMember 2021-03-01 2021-03-09 0001839608 us-gaap:PrivatePlacementMember 2021-01-01 2021-06-30 0001839608 us-gaap:PrivatePlacementMember 2021-06-30 0001839608 2021-03-01 2021-03-09 0001839608 2021-03-09 0001839608 ipva:BusinessCombinationMember 2021-06-30 0001839608 ipva:NonRedeemableCommonStockMember 2021-04-01 2021-06-30 0001839608 ipva:NonRedeemableCommonStockMember 2021-01-01 2021-06-30 0001839608 us-gaap:OverAllotmentOptionMember 2021-01-01 2021-06-30 0001839608 us-gaap:OverAllotmentOptionMember 2021-06-30 0001839608 ipva:PublicWarrantsMember 2021-01-01 2021-06-30 0001839608 ipva:SponsorMember ipva:EarlyBirdCapitalMember 2021-06-30 0001839608 ipva:PrivatePlacementWarrantsMember 2021-06-30 0001839608 ipva:SponsorMember 2021-06-30 0001839608 ipva:PrivatePlacementWarrantsMember ipva:EarlyBirdCapitalMember 2021-06-30 0001839608 ipva:PrivatePlacementWarrantsMember 2021-01-01 2021-06-30 0001839608 ipva:SponsorMember 2021-01-01 2021-01-13 0001839608 ipva:SponsorMember us-gaap:CommonClassBMember 2021-01-01 2021-01-13 0001839608 2021-03-01 2021-03-04 0001839608 ipva:FounderSharesMember ipva:SponsorMember 2021-03-01 2021-03-04 0001839608 ipva:FounderSharesMember ipva:SponsorMember 2021-01-01 2021-06-30 0001839608 ipva:SponsorMember 2021-03-01 2021-03-04 0001839608 ipva:AdministrativeServicesAgreementMember 2021-04-01 2021-06-30 0001839608 ipva:AdministrativeServicesAgreementMember 2021-01-01 2021-06-30 0001839608 ipva:PromissoryNoteMember 2021-01-13 0001839608 srt:VicePresidentMember 2021-01-01 2021-06-30 0001839608 ipva:ServicesAgreementMember 2021-04-01 2021-06-30 0001839608 ipva:ServicesAgreementMember 2021-01-01 2021-06-30 0001839608 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001839608 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001839608 us-gaap:CommonClassAMember ipva:RepresentativeSharesMember 2021-01-01 2021-06-30 0001839608 ipva:RepresentativeSharesMember 2021-01-01 2021-06-30 0001839608 us-gaap:PrivatePlacementMember 2021-03-09 0001839608 us-gaap:PrivatePlacementMember 2021-03-31 0001839608 ipva:UnderwritersWarrantsMember 2021-03-09 0001839608 ipva:UnderwritersWarrantsMember 2021-03-31 0001839608 ipva:UnderwritersWarrantsMember 2021-06-30 0001839608 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001839608 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001839608 2021-03-01 2021-03-31 0001839608 us-gaap:PrivatePlacementMember 2021-03-07 0001839608 ipva:UnderwritersWarrantsMember 2021-03-07 0001839608 us-gaap:PrivatePlacementMember 2021-03-08 2021-03-31 0001839608 ipva:UnderwritersWarrantsMember 2021-03-08 2021-03-31 0001839608 us-gaap:PrivatePlacementMember 2021-04-01 2021-06-30 0001839608 ipva:UnderwritersWarrantsMember 2021-04-01 2021-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure